Association of Serum Ferritin Levels with Disease Severity in NonAlcoholic Fatty Liver Disease

Background: Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide and is closely associated with metabolic syndrome. Serum ferritin, an acute-phase reactant and marker of iron stores, is frequently elevated in NAFLD patients. Objective: To evaluate the association between serum ferritin levels and disease severity in patients with NAFLD. Materials and Methods: This observational study included 50 patients diagnosed with NAFLD based on clinical, biochemical, and ultrasonographic findings. Serum ferritin levels were measured and correlated with liver enzymes, metabolic parameters and NAFLD severity grading. Disease severity was assessed using liver function tests, ultrasonography grading and non-invasive fibrosis markers. Statistical analysis was performed to determine the association between serum ferritin levels and NAFLD severity. Results: The serum ferritin levels in the non-alcoholic fatty liver disease group were significantly higher than those without non-alcoholic fatty liver disease group and levels were elevated in patients with moderate to severe NAFLD compared to those with mild disease. Serum ferritin levels were significantly associated with the risk of non-alcoholic fatty liver disease in both men and women. Ferritin showed a positive correlation with alanine aminotransferase (ALT), aspartate aminotransferase (AST) and body mass index (BMI). Higher ferritin levels were associated with increased hepatic inflammation and fibrosis risk. Conclusion: Serum ferritin levels were higher in patients with non-alcoholic fatty liver disease than in those without non-alcoholic fatty liver disease and were associated with the risk of non-alcoholic fatty liver disease in both men and women and may serve as a useful non-invasive biomarker for assessing hepatic inflammation and fibrosis progression.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-19
DOI
https://doi.org/10.25258/ijddt.16.80s.68
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of Serum Ferritin Levels with Disease Severity in NonAlcoholic Fatty Liver Disease

Bushra Fiza, Kavita Sharma, Bhavana Singha, Shilpa Dhameja et al.
1 links
International Journal of Drug Delivery Technology
Liver Disease Diagnosis and Treatment
article

Association of Serum Ferritin Levels with Disease Severity in NonAlcoholic Fatty Liver Disease

Bushra Fiza, Kavita Sharma, Bhavana Singha, Shilpa Dhameja, Madhu Sharma
article en

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide and is closely associated with metabolic syndrome. Serum ferritin, an acute-phase reactant and marker of iron stores, is frequently elevated in NAFLD patients. Objective: To evaluate the association between serum ferritin levels and disease severity in patients with NAFLD. Materials and Methods: This observational study included 50 patients diagnosed with NAFLD based on clinical, biochemical, and ultrasonographic findings. Serum ferritin levels were measured and correlated with liver enzymes, metabolic parameters and NAFLD severity grading. Disease severity was assessed using liver function tests, ultrasonography grading and non-invasive fibrosis markers. Statistical analysis was performed to determine the association between serum ferritin levels and NAFLD severity. Results: The serum ferritin levels in the non-alcoholic fatty liver disease group were significantly higher than those without non-alcoholic fatty liver disease group and levels were elevated in patients with moderate to severe NAFLD compared to those with mild disease. Serum ferritin levels were significantly associated with the risk of non-alcoholic fatty liver disease in both men and women. Ferritin showed a positive correlation with alanine aminotransferase (ALT), aspartate aminotransferase (AST) and body mass index (BMI). Higher ferritin levels were associated with increased hepatic inflammation and fibrosis risk. Conclusion: Serum ferritin levels were higher in patients with non-alcoholic fatty liver disease than in those without non-alcoholic fatty liver disease and were associated with the risk of non-alcoholic fatty liver disease in both men and women and may serve as a useful non-invasive biomarker for assessing hepatic inflammation and fibrosis progression.

International Journal of Drug Delivery TechnologyVol. 16(80s)
Jagannath University (IN), Gandhi Medical College & Hospital (IN), Mahatma Gandhi Dental College & Hospital (IN), Jagannath University Jaipur (IN)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon